Virtual Kol Event: RZ402 - An Oral Plasma Kallikrein Inhibitor for DME - Wednesday, March 22, 2023 at 4:30 PM Edt

Learn More »

Nonclinical safety and pharmacology of RZ402, a plasma kallikrein inhibitor, for the treatment of diabetic macular edema as a daily oral therapy

Back to Careers